Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

Peyote & Mescaline

A Sacred Cactus, a Protected Sacrament, a Studied Molecule

Evidence grade 1 of 5, Untested. Read how the Atlas grades evidence.

Rigorous modern clinical research on peyote/mescaline is sparse compared with psilocybin, largely because of legal restriction and respect for its sacred, conservation-sensitive status. Observational and survey research within Native American Church communities has reported low rates of harm and possible benefits for alcohol-use disorder in that ceremonial context, consistent with the broader psychedelic-and-addiction signal, but this is not the same as controlled trials. The honest tier is "traditional/ceremonial use with limited formal study," a practice whose value is attested culturally and supported by suggestive but not definitive research.

Reference only. Not medical advice.

What can go wrong

Mescaline has low physiological toxicity, but it carries the serious psychological risks common to serotonergic psychedelics: frightening experiences, and the potential to trigger prolonged anxiety, psychosis, or mania in people who are vulnerable, particularly those with a personal or family history of psychotic or bipolar illness. Acute physical effects seen in clinical dosing include raised blood pressure, heart rate, and body temperature, with nausea and vomiting common at higher doses. Anyone considering psychedelics, and especially anyone with a mental-health history or who is pregnant, should first consult a qualified medical or mental-health provider. Two non-medical dimensions matter as much as the pharmacology. The plant is slow-growing and threatened by overharvesting, so casual harvesting causes real ecological harm. And in the US, sacramental use is legally protected only for Native Americans practicing a traditional religion; use outside that context is generally illegal. This entry documents a protected religious practice and a research-relevant molecule. It is not a how-to and not an invitation to take up a sacred, ecologically fragile medicine.

Peyote is a small, slow-growing desert cactus whose crowns hold mescaline, a serotonergic psychedelic in the same broad family as psilocybin. Its ceremonial use in the Chihuahuan Desert borderlands runs at least 5,700 years deep, confirmed by mescaline recovered from radiocarbon-dated cave specimens in Texas. It remains central to the Wixarika (Huichol) pilgrimage to Wirikuta in Mexico and is the sacrament of the Native American Church, taken in all-night prayer meetings for healing and community. Formal clinical research is thin, held back by the plant's Schedule I status, its sacred meaning, and its fragile conservation, so the strongest human evidence is observational: a Navajo cohort showed no cognitive harm from regular ceremonial use, and self-report surveys of mescaline users describe low craving and perceived help with drinking. The plant itself is threatened by overharvesting, which is why the tradition-bearers ask that it stay reserved for ceremony.

A sacred cactus used ceremonially for millennia and protected as a Native American Church sacrament, its molecule mescaline studied, its plant threatened, its use legally and culturally bounded.

How it is supposed to work

Mescaline is a serotonergic psychedelic (acting at 5-HT2A receptors, like psilocybin and LSD), producing altered perception and a profound subjective experience. In ceremonial use the prolonged, supported, communal setting shapes the experience as much as the molecule.

What people get wrong

  • Often saidPeyote is just a recreational drug.

    ActuallyTo its tradition-bearers it is sacred medicine taken inside ceremony, used for thousands of years and protected as a religious sacrament. Archaeological specimens containing mescaline date ceremonial use to roughly 5,700 years ago (El-Seedi et al., Journal of Ethnopharmacology, 2005), and outside protected religious use it is illegal under US federal law.

  • Often saidAnyone can legally use peyote because it is natural and ceremonial.

    ActuallyIn the US, sacramental peyote use is lawful specifically for Native Americans practicing a traditional Indian religion under the 1994 amendment to the American Indian Religious Freedom Act. Peyote and mescaline otherwise remain Schedule I. Recent decriminalization measures in Colorado and Oregon explicitly exclude peyote at the request of Native churches.

  • Often saidMescaline works exactly like other psychedelics, so peyote can be swapped freely for synthetic mescaline.

    ActuallyThe molecule is shared, but the plant is not interchangeable with the compound. Peyote is slow-growing and threatened, so most Indigenous organizations ask that non-Native users turn to synthetic mescaline or the more abundant San Pedro cactus rather than harvesting peyote, which the IUCN lists as Vulnerable.

Who profits, and who pushes back

  • Native American Church

    endorsesSacramental tradition

    Holds peyote as a sacred sacrament for healing, prayer, and community, used in supported all-night ceremonies and protected as religious practice.

  • Wixarika (Huichol) tradition-bearers

    endorsesIndigenous cultural authority

    Center peyote in pilgrimage and cosmology and raise alarm over overharvesting and appropriation threatening the plant and the practice.

  • Psychedelic/addiction researchers

    caveatsSurvey and observational studies

    Report low harm and possible benefit for alcohol-use disorder among ceremonial users, while noting formal controlled research on mescaline remains limited.

  • Conservation & legal experts

    cautionsEcology and law

    Warn that peyote is slow-growing and threatened, and that use outside protected sacramental contexts is illegal in much of the US.

Where the research comes from

Most of the published research on this comes from one place. 100% of it is from Sacramental use protected for Native American Church members (US). Findings that no unrelated group has reproduced are weaker than the study count makes them look.

Share of published research by country of origin.
PlaceShare of published research
Sacramental use protected for Native American Church members (US)100%

How we got here

The oldest hard evidence sits in Texas: peyote crowns from Shumla Cave No. 5 on the Rio Grande were radiocarbon dated to roughly 3780 to 3660 BC and still contained mescaline, placing recognition of the plant's effects around 5,700 years ago (El-Seedi et al., 2005). Among the Wixarika of the Sierra Madre Occidental, peyote (hikuri) anchors a living tradition and an annual pilgrimage of several hundred miles to Wirikuta in San Luis Potosi, the desert where their ancestors first gathered it. After the Spanish conquest, colonial and Inquisition authorities condemned peyote as diabolic and banned it by edict in 1620. From the 1880s, figures such as the Comanche leader Quanah Parker carried peyotism across Plains tribes, and adherents incorporated the Native American Church in Oklahoma in 1918 to defend the practice. Mescaline was isolated by Arthur Heffter in 1897 and synthesized by Ernst Spath in 1919, drawing the molecule into Western science and letters.

  1. c. 3700 BCPeyote crowns later found in Shumla Cave, Texas are used ceremonially; mescaline survives in the specimens, dating recognition of the plant's effects to roughly 5,700 years ago
  2. 1620Spanish colonial Inquisition in New Spain issues an edict banning peyote as diabolic, one of the first documented prohibitions of a psychoactive plant in the Americas
  3. 1897-1919Arthur Heffter isolates mescaline from peyote (1897); Ernst Spath achieves its chemical synthesis (1919), bringing the molecule into Western science
  4. 1918An intertribal coalition incorporates the Native American Church in Oklahoma to protect ceremonial peyote use against prohibition
  5. 1990In Employment Division v. Smith, the US Supreme Court rules that neutral drug laws need not exempt sacramental peyote use, removing prior protection
  6. 1994Congress amends the American Indian Religious Freedom Act, making bona fide ceremonial peyote use by Native Americans lawful nationwide
  7. 2005Halpern and colleagues publish an observational study of Navajo Native American Church members finding no cognitive or psychological deficits from long-term ceremonial peyote use
  8. 2017The IUCN Red List assessment classifies Lophophora williamsii as Vulnerable with a declining population
  9. 2024First modern randomized, double-blind, placebo-controlled trial of oral mescaline (100 to 800 mg) characterizes dose-response and 5-HT2A dependence in healthy volunteers
  10. 2025UNESCO inscribes the Wixarika pilgrimage route to Wirikuta on the World Heritage List; Navajo Nation and Native churches press to keep peyote out of broad decriminalization to protect the supply

How it is understood

Peyote (Lophophora williamsii), a small spineless cactus of northern Mexico and the US Southwest, has been used ceremonially for millennia, archaeological specimens date back thousands of years. For the Wixarika (Huichol) people it is central to pilgrimage and cosmology; in the Native American Church it is a protected sacrament taken in all-night prayer ceremonies for healing, community, and spiritual connection. Its active compound, mescaline, is also found in some South American cacti (San Pedro/huachuma), used in Andean traditions. This is sacred medicine embedded in living religious practice, not a recreational drug to its tradition-bearers.

At a glance

Plant
Peyote (Lophophora williamsii); mescaline is the active compound
Traditional use
Millennia; Wixarika pilgrimage, Native American Church
US legal status
Protected sacrament for NAC members; otherwise illegal
Conservation
Slow-growing, threatened by overharvest

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about Peyote & Mescaline. A short entry is not a safe entry.

  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.
  • What people take it for. We have not catalogued the claims made for it.

Sources